Leftagraph

Every financial statement,
one clean chart.

Search any US-listed company. Data straight from SEC filings.

PROBuild your own list with the screener

ORAGENICS, INC. (OGEN) financial statements

Number look wrong? Tell us

Data table
PROBuild your own list with the screener

ORAGENICS, INC. (OGEN), most recent 12 months reported: net loss $10.08M. Latest balance sheet on file: liquid cash $3.86M. From SEC filings. Others in Pharmaceutical Preparations: Nuvectis Pharma, Inc. · NEXTCURE, INC · NEXENTIS TECHNOLOGIES INC. · OBSIDIAN THERAPEUTICS, INC. · ONKURE THERAPEUTICS, INC. · OLEMA PHARMACEUTICALS, INC. · OMEROS CORP · ONCOLYTICS BIOTECH INC.

Stock screener

Watchlist